<DOC>
	<DOC>NCT00004670</DOC>
	<brief_summary>OBJECTIVES: I. Evaluate the safety and efficacy of pallidotomy immediately following 3 preoperative assessments vs. delayed pallidotomy following 6 months of standard medical therapy in patients with Parkinson disease.</brief_summary>
	<brief_title>Phase II Study of Pallidotomy for Parkinson Disease</brief_title>
	<detailed_description>PROTOCOL OUTLINE: This is a randomized study. One group of patients undergoes the surgical procedure pallidotomy, a precise lesioning of brain cells in the globus pallidus. The other group receives standard medical care for 6 months followed by a pallidotomy.</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA: Disease Characteristics Idiopathic Parkinson disease Hoehn and Yahr stage III or worse during "off" periods Responsive to levodopa by history or exam Suboptimal clinical response to maximal medication Medication optimized for at least 4 weeks prior to entry No atypical or secondary disease, e.g.: No history of cerebrovascular accident No cerebellar involvement No severe brain atrophy on magnetic resonance imaging No Mattis Dementia Rating Scale score less than 116 No dementia meeting Diagnostic and Statistical Manual of Mental DisordersIV criteria No Hamilton Depression Rating Scale score greater than 10 No Hamilton Anxiety Scale score greater than 14 Patient Characteristics Other: No medical contraindication to surgery, e.g.: Diabetes Cardiopulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>Parkinson disease</keyword>
	<keyword>neurologic and psychiatric disorders</keyword>
	<keyword>rare disease</keyword>
</DOC>